Rachel Melamed

3.8k total citations · 1 hit paper
23 papers, 2.8k citations indexed

About

Rachel Melamed is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Rachel Melamed has authored 23 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Immunology and 4 papers in Genetics. Recurrent topics in Rachel Melamed's work include T-cell and B-cell Immunology (5 papers), Bioinformatics and Genomic Networks (4 papers) and Computational Drug Discovery Methods (3 papers). Rachel Melamed is often cited by papers focused on T-cell and B-cell Immunology (5 papers), Bioinformatics and Genomic Networks (4 papers) and Computational Drug Discovery Methods (3 papers). Rachel Melamed collaborates with scholars based in United States, Germany and Canada. Rachel Melamed's co-authors include Peter O. Krutzik, Olga Ornatsky, Robert Balderas, Karen Sachs, Dana Pe’er, Robert V. Bruggner, Peng Qiu, Garry P. Nolan, Rachel Finck and Angelica Trejo and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Rachel Melamed

19 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum

2011 1.7k citations Rachel Melamed et al. profile →

Peers

Countries citing papers authored by Rachel Melamed

Since Specialization

Citations

This map shows the geographic impact of Rachel Melamed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Melamed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Melamed more than expected).

Fields of papers citing papers by Rachel Melamed

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Melamed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Melamed. The network helps show where Rachel Melamed may publish in the future.

Co-authorship network of co-authors of Rachel Melamed

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Melamed. A scholar is included among the top collaborators of Rachel Melamed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Melamed. Rachel Melamed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exploiting similarity in drug molecular effects for drug repurposing 2025 ·Human Genomics ·(unknown), (unknown), (unknown), Rachel Melamed	0
2	Drug combination-wide association studies of cancer 2025 ·Communications Medicine ·(unknown), Rachel Melamed	0
3	Shared etiology of Mendelian and complex disease supports drug discovery 2024 ·BMC Medical Genomics ·(unknown), Rachel Melamed	0
4	Mapping drug biology to disease genetics to discover drug impacts on the human phenome 2024 ·Bioinformatics Advances ·(unknown), (unknown), Rachel Melamed	0
5	Development and application of an evidence-based directed acyclic graph to evaluate the associations between metal mixtures and cardiometabolic outcomes 2023 ·PubMed ·(unknown), Rachel Melamed, Katherine A. James, Tanya L. Alderete, Laura Corlin	1
6	Associations Between Natural Language Processing–Enriched Social Determinants of Health and Suicide Death Among US Veterans 2023 ·JAMA Network Open ·Avijit Mitra, Richeek Pradhan, Rachel Melamed, Kun Chen, David C. Hoaglin, Katherine L. Tucker, Joel I. Reisman, Zhichao Yang, Weisong Liu, Jack Tsai, Hong Yu	28
7	Effects of Antidepressants on COVID-19 Outcomes: Retrospective Study on Large-Scale Electronic Health Record Data 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Rachel Melamed, (unknown)	2
8	A Longitudinal Study of Exposure to Manganese and Incidence of Metabolic Syndrome 2022 ·Nutrients ·(unknown), Kenneth Chui, Katherine A. James, Rachel Melamed, Tanya L. Alderete, Laura Corlin	8
9	Using indication embeddings to represent patient health for drug safety studies 2020 ·JAMIA Open ·Rachel Melamed	4
10	Patchwork of contrasting medication cultures across the USA 2018 ·Nature Communications ·Rachel Melamed, Andrey Rzhetsky	3
11	Genomic Characterization of Dysplastic Nevi Unveils Implications for Diagnosis of Melanoma 2016 ·Journal of Investigative Dermatology ·Rachel Melamed, Iraz T. Aydin, (unknown), Robert Phelps, David N. Silvers, Kevin Emmett, Georg Brunner, Raúl Rabadán, Jülide Tok Çelebi	35
12	An information theoretic method to identify combinations of genomic alterations that promote glioblastoma 2015 ·Journal of Molecular Cell Biology ·Rachel Melamed, Jiguang Wang, Antonio Iavarone, Raúl Rabadán	15
13	Genetic similarity between cancers and comorbid Mendelian diseases identifies candidate driver genes 2015 ·Nature Communications ·Rachel Melamed, Kevin Emmett, Chioma J. Madubata, Andrey Rzhetsky, Raúl Rabadán	28
14	FBXW7 Mutations in Melanoma and a New Therapeutic Paradigm 2014 ·JNCI Journal of the National Cancer Institute ·Iraz T. Aydin, Rachel Melamed, (unknown), Mireia Castillo-Martín, Ahu Yorulmaz, (unknown), Georg Brunner, Carlos Cordon‐Cardo, Iman Osman, Raúl Rabadán, Jülide Tok Çelebi	68
15	A Nondegenerate Code of Deleterious Variants in Mendelian Loci Contributes to Complex Disease Risk 2013 ·Cell ·David Blair, Christopher S. Lyttle, Jonathan Mortensen, Carrie E. Bearden, Anders Boeck Jensen, Hossein Khiabanian, Rachel Melamed, Raúl Rabadán, Elmer V. Bernstam, Søren Brunak, Lars Juhl Jensen, Dan L. Nicolae, Nigam H. Shah, Robert L. Grossman, Nancy J. Cox, Kevin P. White, Andrey Rzhetsky	153
16	GAB2 induces tumor angiogenesis in NRAS-driven melanoma 2012 ·Oncogene ·Yong‐Guang Yang, Jinhua Wu, (unknown), Mireia Castillo-Martín, Rachel Melamed, (unknown), (unknown), Rolando Pérez‐Lorenzo, Bin Zheng, David N. Silvers, Georg Brunner, Shuang Wang, Raúl Rabadán, Carlos Cordon‐Cardo, Jülide Tok Çelebi	25
17	The variable immunological self: Genetic variation and nongenetic noise in Aire-regulated transcription 2008 ·Proceedings of the National Academy of Sciences ·Emily S. Venanzi, Rachel Melamed, Diane Mathis, Christophe Benoıst	44
18	Sustained antigen presentation can promote an immunogenic T cell response, like dendritic cell activation 2007 ·Proceedings of the National Academy of Sciences ·Reinhard Obst, Hisse M. van Santen, Rachel Melamed, Alice O. Kamphorst, Christophe Benoıst, Diane Mathis	63
19	Foxp3 Transcription-Factor-Dependent and -Independent Regulation of the Regulatory T Cell Transcriptional Signature 2007 ·Immunity ·Jonathan A. Hill, Markus Feuerer, Kaley Tash, Sokol Haxhinasto, Jasmine T. Perez, Rachel Melamed, Diane Mathis, Christophe Benoıst	487
20	Gene expression microarrays: glimpses of the immunological genome 2006 ·Nature Immunology ·(unknown), Rachel Melamed, Richard Park, (unknown), Catherine Laplace, Laurent Poirot, S. Zucchelli, Reinhard Obst, (unknown), Emily S. Venanzi, Ananda W. Goldrath, Linh T. Nguyen, John A. Luckey, Tetsuya Yamagata, Ann Herman, Jonathan P. Jacobs, Diane Mathis, Christophe Benoıst	59

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact